Delivery Order SPE2DB25D9305-SPE2DB25FQAEA

Award Date 4/16/25
Potential Completion Date 5/7/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,634.90, is for the supply of 4,565,752,490 doses of the YF-VAX 1 vaccine. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which runs through December 31, 2025. The IDC allows...
This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,113.42, is for the delivery of 4,568,091,643 doses of the YF-VAX vaccine with an ultimate completion date of May 14, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. DMS Pharmaceutical Group Inc. holds a significant single-award...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $8,350.65 for the supply of 4,568,187,300 doses of the YF-VAX vaccine. The contract has a firm fixed price and an ultimate completion date of May 27, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,126.98 firm fixed-price contract is for the provision of 4,565,859,936 doses of the YF-VAX 1 vaccine, with a completion date of October 1, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,568,429,654 units of the YF-VAX 1 dose vaccine, with a ceiling value of $3,340.26 and a completion date of June 18, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,507.92 firm fixed-price delivery order is for 4,565,058,721 doses of the YF-VAX vaccine, with a completion date of July 3, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,783.55 firm fixed-price delivery order is for the supply of 4,568,274,955 doses of the YF-VAX vaccine. The contract has a completion date of June 4, 2025 and was awarded on May 13, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $55,671.00, is for the delivery of 4,567,998,768 doses of the YF-VAX 1 vaccine. The order has an ultimate completion date of May 8, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $1,690.47 firm fixed-price delivery order for the supply of a single dose of the YF-VAX vaccine. The contract has an ultimate completion date of November 8, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,269.80 firm fixed-price delivery order is for the supply of 4,566,384,222 doses of the YF-VAX vaccine. The award is not associated with a specific set-aside designation. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
  • SPE2DB25D9305
    Indefinite Delivery Contract
  • SPE2DB25D9305-SPE2DB25FQAEA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,340.26, is for the delivery of 4,568,028,048 doses of the YF-VAX vaccine with a completion date of May 7, 2025.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories.

Generated 7/16/25, 12:22 PM